INTRODUCTION
(SRL), and mycophenolate mofetil (MMF)] (3). Cyclosporine was the first immunosuppressant to be developed. While it suppresses T-cell activation, long-term Neural transplantation is an important alternative treatment in neurodegenerative diseases, such as Parkin-use can induce hepatotoxicity (13), nephrotoxicity (22), cardiovascular toxicity (30) , and encephalopathy (8) . A son's disease (PD). Fetal tissue is the standard source of dopamine (DA)-producing neurons to substitute for better approach would be to provide localized immunosuppression to the graft site. those lost in the process of the neural degeneration. However, the use of human fetal tissue is limited be-Sertoli cells (SCs) are testis-derived cells, one of whose functions is to provide immunoprotection to germ cause of ethical issues and problems of limited availability. As a result, studies have been conducted to examine cells in the testes. SCs secrete many immunoprotective factors, including interleukin-2 (IL-2) (12,38) and insu-the feasibility of using tissues from different species (xenografts). However, xenotransplantation is a compli-lin growth factor-1 (IGF-1) (21, 32) , which inhibit lymphocytic proliferation. Transforming growth factor-β (TGF-cated issue, with concerns over zoonotic transmission of disease and increased chances of graft rejection (2, 9) . β) (39) modulates immune response by transforming the Th1 response involved in severe rejection (31) . IL-1 and The survival of xenotransplants depends on appropriate long-term immunosuppressive treatment (25, 40) .
IL-6 (10) are also produced by SCs. These cytokines are involved in autocrine regulation of SCs and at the same These treatments are usually a combination of two or three drugs to produce maximum immunosuppression time influence the differentiation of DA neurons in vitro (28) . These special properties of SCs might be useful in [e.g., cyclosporine (CsA), tacrolimus (TRL), sirolimus solving the problem of long-term immunosuppression months without cyclosporine immunosuppression (37). These results suggest that SCs can overcome the xeno-and at the same time help the cotransplanted neurons to engraft in the host striatum. SCs have also been used as geneic barrier. The aim of this study was to determine if the SCs graft enhancers in experimental islet transplants for diabetes. When porcine islet cells were transplanted in the tes-that had been optimized for their ability to enhance the expression of tyrosine hydroxylase (TH) in ventral mes-ticular interstitial space of cryptorchid dogs, these xenogeneic grafts survived in the intra-abdominal testis without encephalon (VM) in vitro (41) would be effective at enhancing the survival of TH-positive neurons when the the use of immunosuppression whereas xenotransplants in the subcapsular space of the liver did not (20).
SCs and/or the VM cells were transplanted across species. In addition, we examined the possible rejection re-SCs have also been used in neural transplantation in PD models. In a study done to evaluate the neurobehav-sponse to allografts and xenografts in the mouse. ioral changes following porcine SC transplantation into the intact rat striatum (36) , there were fewer behavioral MATERIALS AND METHODS changes in animals with the xenotransplanted porcine
Cotransplantation of Rat SCs (rSCs) With Either SCs compared to the media only transplants, indicating
Rat VM (rVM) (Xenograft) or Mouse VM (mVM) that the SCs are tolerated by the host tissue and do not (Allograft) in a Mouse Model disrupt motor circuitry; further the SCs survived in the striatum of rats for 4 weeks without evidence of graft Animals. One hundred and five C57BL/J6 male mice weighing 20-25 g at time of surgery were stereotactic-rejection. Saporta and colleagues showed that rat and porcine SCs can survive in the rat striatum up to 2 ally transplanted with either rSCs only (n = 17), rVM only (n = 18), rVM + rSCs (n = 20), mVM only (n = Ventral Mesencephalon Isolation. The rVM from 12-14-day-old rat embryos or mVM from 13-15-day-20), or mVM + rSCs (n = 16). Fourteen animals died prematurely and were excluded from the analysis. The old mouse embryos were dissected into oxygenated HBSS (Gibco BRL) + 15 mM HEPES (Gibco BRL) and animals were housed with free access to food and water in a temperature-controlled room on a 12:12 h light the tissue incubated for 20 min at 37°C in 0.25% trypsin + 0.1% EDTA (Sigma) and 0.05% DNase (Sigma) in cycle.
HBSS/HEPES. The tissue pieces were rinsed five times Sertoli Cell Isolation. The SCs were isolated from with 0.05% DNase and mechanically dissociated. The 15-17-day-old rats. The tunica albuginae was removed cell number and cell viability were assessed with the from the individual testis; the testicular parenchyma was trypan blue dye exclusion method. The cell concentrapooled and then subjected to sequential enzymatic digestion was adjusted to 100,000 cell/µl prior to transplantation with trypsin (0.25%) and collagenase (0.1%) at tion. 37°C (6) . The resulting SC aggregates were plated in Transplantation Procedures. Normal C57BL/J6 mice 100-mm tissue culture wells in DMEM:F12 (Gibco, were anesthetized with Equithesin (3.5ml/kg, IP) and BRL) supplemented with 0.1% ITS (Sigma), 50 ng/ml positioned in a Kopf stereotactic frame. The skin over retinol acetate (Sigma), 50 µg/ml gentamicin sulfate the cranium was incised, bregma located, and a hole (Sigma), and 10% fetal bovine serum (FBS) and incudrilled over the transplant site. The coordinates for the bated at 39°C in 5% CO 2 /95% air for 48 h to remove transplant site were 0.8 mm anterior to bregma, +1.7 germ cells. The cultures were washed twice and returned mm laterally, and −1.9 and −2.2 mm ventral to the dura to the CO 2 -injected incubator at 37°C in 5% CO 2 /95% with the tooth bar set at zero. For VM + SCs cotransair for an additional 48 h (96 h total). Using this proceplant groups, the cells were mixed just prior to surgery dure, resulting cultures contained greater than 95% SCs. and loaded into a 10-µl Hamilton syringe. The cell sus-Sertoli Cell Transplantation. The SCs were harpension of SCs and VM was injected through a 31vested from culture 96 h after isolation and centrifuged gauge needle into two sites in the striatum along a single twice at 800 rpm for 2-3 min in DMEM. The SCs were needle tract. Each injection of 2 µl was delivered at a then prelabeled with cholera toxin subunit B (CTb) conrate of 1 µl/min for a total of 400,000 cells in 4 µl total. jugated to FITC for graft identification. The SCs were
The needle was left in place for 5 min after the injection incubated with CTb for 20 min at 4°C in the dark as and then withdrawn slowly. The wound was closed with previously described (4) . The cells were washed with Vetbond. PBS. All SCs were labeled. The viability of SCs was Immunohistochemistry. At 1 or 2 weeks or 2 months assessed using trypan blue dye exclusion and cell conafter transplantation, the mice were anesthetized with centration adjusted to 100,000 cells/µl. 
pentobarbital (40 mg/kg) and transcardially perfused
Dose-Response Relationship in the Mouse Xenograft Model with 0.1 M phosphate buffer followed by 50 ml of 10% formalin in 0.1 M phosphate buffer. The brain was re-In this study, we wished to determine if the ratio of moved, postfixed for 24 h, cryoprotected with 20% su-VM:SC affected the survival of TH-positive neurons in crose, and then sectioned at 30 µm in a cryostat. All the host striatum. immunohistochemistry was performed on free-floating Animals. Twenty-four C57BL/J6 male mice weighsections. After blocking using 10% normal goat serum ing 20-25 g at time of surgery were assigned to rVM (NGS), the sections were incubated with primary antionly (n = 6) or rVM + rSC (n = 13). Five animals died body [rabbit polyclonal TH (1:350, Pel Freez), rabbit (one from the VM only group and four from the VM + polyclonal GFAP (1:750, Dako), or rat monoclonal SC) and were excluded from analysis. MHC II (I-A/I-E 1:300, Pharmingen)] overnight at 4°C. The sections were then rinsed and incubated in goat anti-Sertoli Cell Isolation and Transplantation. The SCs rabbit or goat anti-rat rhodamine secondary antibody (1:
were isolated as described above. The cell concentration 200 Alexa 594, Molecular Probes). After rinsing, the was adjusted to either 20,000 or 100,000 cells/µl in a sections were coverslipped with glycerol and examined ratio of 5 VM:1 SCs or 1 VM:2 SCs, respectively. under epifluorescence with an Olympus BX40 research Ventral Mesencephalon Preparation. The VM cells microscope. Photomicrographs were taken using the digwere prepared and transplanted as described above. ital Optronics camera.
At least two animals in each group were assigned for Transplantation Procedures. The cells were transcounting. Sections were made through the entire striaplanted as described above; two ratios of rVM:rSC were tum. The sections were processed for TH immunostainused. In the 5:1 VM:SC group the total transplant was ing. All the immunolabeled cells within the graft were 120,000 cells, whereas animals in the 1:2 VM:SC group individually counted using the fluorescent light microreceived 300,000 cells. scope. The average number of surviving TH-positive At 1 week posttransplant all animals were euthanized. neurons and CTb-positive SCs was estimated through
All the grafts in this study were examined and counted. the entire extent of the striatal graft. The number of TH All TH-positive cells were individually counted on a fluand CTb labeled cells was adjusted according to the orescent microscope. Every sixth section was counted method of Abercrombie (1) .
throughout the graft with a minimum of three sections per animal. The average number of surviving TH-Statistical Analysis. Data are reported as means ± SD and were analyzed using analysis of variance (ANOVA).
positive neurons in striatal grafts of all the animals was estimated using Abercrombie's formula (1). Differences were significant if p < 0.05.
Statistical Analysis. Data are reported as means ± SD
Cultures of rVM alone were seeded as described for the SCs. After 5 DIV, the cultures were fixed with 4% and analyzed using Student's t-test. Significance was defined as p < 0.05. paraformaldehyde in PBS and immunohistochemistry was performed.
Expression of Immune Markers In Vitro
Immunohistochemistry. The cultures were blocked using 10% normal goat serum (NGS) or 10% normal Culture. Rat SC cultures were seeded at a density of 200,000 cells/cm 2 on poly-L-lysine (10 ml/ml; Sigma) horse serum (NHS) and incubated overnight at 4°C in primary antibody. The primary antibodies employed coated eight-well chamber slides (Nunc) or 35-mm dishes (Fisher Scientific) in DMEM with 10% FBS and were polyclonal rabbit TGF-β (1:1000, Promega), mouse monoclonal IGF-1 (1:100, Upstate Biotechnol-50 µg/ml gentamicin, 50 ng/ml retinol acetate (Sigma), 50 µg/ml gentamicin sulfate (Sigma). After 24 h the me-ogy), ox-6 mouse monoclonal antibody to MHC class II (anti 1-A, 1:300, Serotec), and ox-18 mouse monoclonal dium was changed to DMEM:F12, 50 µg/ml gentamicin, 50 ng/ml retinol acetate (Sigma), and 0.1% ITS. The antibody to MHC class I (1:300, Cedarlane Laboratories). The cultures were then rinsed and incubated with cultures were fixed with 4% formaldehyde in PBS after 5 days in vitro (DIV) and immunohistochemistry was goat anti-rabbit or horse anti-mouse antibody (1:300, Vector Laboratories) for 60 min. Following rinsing, the performed. ABC solution (Vector) was applied for 60 min. After to 100%. By 2 months posttransplant, few of the animals in either group had surviving grafts. In contrast, 80-rinsing, the chromagen (VIP, Vector) was applied for 10 min. To ensure that staining was specific, some cultures 100% of the animals in both the mVM group and the mVM + rSCs group had surviving grafts even at the went through the same process but primary antibody was omitted. The cultures were rinsed, coverslipped, and long-term endpoint (2 months). The worst survival was observed in the SC-only group; while cells were found examined on the Olympus IX50 inverted microscope and photomicrographs taken using the Optronics digital in 80% of the animals at 1 and 2 weeks posttransplant, by 2 months posttransplant we found cells in only 28% camera.
of the animals.
RESULTS
Tyrosine Hydroxylase Expression. The TH-positive Cotransplantation of rSC With Either rVM (Xenograft) cells that were observed in the rVM group (1 week 27.3 ± or mVM (Allograft) in the Mouse Model 24.7, 2 weeks 87.6 ± 46, and 2 months 39.8 ± 46) were mainly small uni-or bipolar neurons ( Fig. 2A and B) . Graft Survival. The number of animals that had some surviving cells as determined by identification of The cells were observed mainly within the narrow needle tract, especially at 2 months posttransplant when few TH-positive VM neurons and CTb-positive SCs is reported as a percentage (Fig. 1) . The percentage of ani-TH-positive cells were observed (Fig. 2B, Fig. 3 ). This was also true in the rVM + rSCs group (1 week 17.1 ± mals with surviving grafts in the rVM group and rVM + rSCs group at 1 week posttransplant varied from 80% 0.9, 2 weeks 51.3 ± 54, and 2 months 23.5 ± 8.83) ( Fig. 2C-E). In contrast to the observations in those groups groups prevented these differences from gaining significance. that were transplanted with rVM, the mVM transplants had many healthy looking TH-positive neurons at all Sertoli Cell Survival. The SCs were visible in all groups in which they were transplanted (Fig. 2C , D, time points examined (1 week 172.7 ± 151, 2 weeks 119.9 ± 126.7, and 2 months 162.5 ± 12.5) ( Fig. 2F-H) ; I-K, Fig. 4 ). In the SC-only group, SCs were visible in the transplant site particularly at 1 week (72.9 ± 57.9) there were approximately twice as many TH-positive neurons surviving in this group compared to the rVM and 2 weeks posttransplant (23.4 ± 12.5) ( Fig. 4A and  B) . At 2 months few SCs were visible (Fig. 4C ). This group (Fig. 3 ). In the mVM + rSCs group (1 week 65.8 ± 54, 2 weeks 13.6 ± 20.1, and 2 months 10. 8 ± 11.6) tendency was verified when the cells were counted (Fig.  5 ). In rSCs with rVM, there were more visible SCs at 1 the number of surviving TH-positive neurons declined to even less than observed in the rVM and rVM + rSCs week (98.3 ± 120) and 2 weeks (27.3 ± 13.5). However, very few SCs were detected at 2 months. In rSCs with groups ( Fig. 2I-K, Fig. 3 ). The large variability between mVM, there were many surviving SCs at 1 week (516.2 marcation between the astrocytes and the graft with few astrocytic processes infiltrating into the graft (Fig. 6F ). ± 512) and 2 weeks (37.5 ± 51.2). At 2 months posttransplant, few SCs could be detected. (There is also a Microglia infiltrated the graft site in all the conditions (allograft and xenograft) ( Fig. 7) . Activated microglia possibility that at 2 months posttransplant, SCs were still present in the transplant but they lost their cholera toxin showed MHC II expression with some morphological changes (19). In mVM transplants there were fewer mi-FITC label). The differences between groups were not significant.
croglia responses at the graft site ( Fig. 7A ). There appeared to be extensive microglial infiltration in the xe-Immune Response to Transplants Within the Brain.
nograft conditions, particularly in the rVM transplants There were differences between the groups with respect (Fig. 7B) , and the rSCs transplants at 2 weeks posttransto the inflammatory response in the brain. When mVM plant (Fig. 7C ). The rVM + rSCs (double xenograft) miwas transplanted alone, GFAP-labeled astrocytes were croglial response at 1 week posttransplant ( Fig. 7D ) and evenly distributed throughout the grafted striatum at 1 2 weeks posttransplant (Fig. 7E ) was similar to that seen week posttransplant (Fig. 6A ). This distribution of astroin the single xenograft condition. This microglial recytic labeling was maintained at all time points examsponse became less extensive at 2 months posttransplant ined for the mice transplanted with mVM. When mVM in all conditions (data not shown). was transplanted with rSCs, the pattern of astrocytic labeling changed. GFAP-positive astrocytes surrounded Dose-Response Relationship in the Mouse the graft at 1 week with few astrocytes infiltrating into Xenograft Model the transplant; this produced a demarcation between the transplant and the host striatum (Fig. 6B ) that was pres-In this experiment we implanted cells at ratios of 5:1 (rVM:rSCs) and 1:2 (rVM:rSCs) in the host striatum. In ent at all time points examined. As with the mVM + rSCs transplants, the GFAP-labeled astrocytes in the the 1:2 (rVM:rSCs) condition at 1 week posttransplant, some small underdeveloped TH-positive neurons were SC-only group did not infiltrate the graft (Fig. 6C ) and the SCs remained within the injected site ( Fig. 6D) (Fig. 8A) . In contrast, when the cells were and 2 weeks posttransplant. In the rVM transplant group there was extensive astrocytic infiltration throughout the transplanted 5:1 (rVM:rSCs), many TH-positive neurons were present within the host striatum at 1 week post-xenograft at 1 week ( Fig. 6E ) and 2 weeks posttransplant, which decreased at 2 months posttransplant. When transplant (rVM, 10.99 ± 4.5 and rVM + rSCs, 24.8 ± 20.8; p < 0.2) (Fig. 8B) . More TH-positive neurons were rSCs were transplanted with rVM, there was a clear de-found in the 5:1 rVM:rSC group than in the 1:2 group most all SCs in vitro (Fig. 10G) . Little IGF-1 immunostaining was also detected in the SC cultures ( Fig. 10H ). (p < 0.03) ( Fig. 9 ).
Expression of Immune Markers In Vitro DISCUSSION
The purpose of this study was to determine the effec-In order to identify the immunogenicity of the SCs and/or their ability to modulate the host immune re-tiveness of SCs at enhancing TH expression when SCs and VM cells were transplanted across species. In con-sponse, we examined the expression of MHC I and MHC II by rSCs and rVM neurons in vitro. The rSCs trast to the observations with allografted SCs (42), the xenografted SCs did not increase the number of surviv-express little or no MHC II antigen (Fig. 10D) , which means there is little likelihood of the cells activating ing TH-positive neurons in the mouse striatum. SCs expressed MHC I but not MHC II antigens in vitro, which lymphocytes within the transplant. However, these SCs express MHC I antigen (Fig. 10A) , which is important may explain the poor survival of SCs after 2 months in situ, because they could be recognized as foreign by the for the recognition of self from non-self. In contrast, VM expressed little MHC I or II antigens ( Fig. 10B and E) .
immune system. While the number of surviving TH-positive cells did To determine the protective effect of SCs against graft rejection, we examined the expression of two tro-not increase with transplantation of rSCs with rVM at a ratio of 1:1, there was an increase in TH-positive neu-phic factors, TGF-β and IGF-1. These trophic factors were previously suggested to play a major role in im-rons at 1 week posttransplant when rSCs were transplanted with rVM cells (xenograft) at a ratio of VM: mune protection by SCs. TGF-β was expressed in al- SCs, 5:1. These results are consistent with a previous by astroglia (29) . These substances (chondroitin-6-sulphate proteoglycan and cytotactin/tenascin) have inhibitory ef-study done to determine the dose-response effect of porcine SC coculture with rVM neurons. The number of fects on neurite outgrowth. This might be the case with SC grafts. However, astrocytes have the ability to se-TH-positive cells was significantly increased in all doses of VM:SCs (10:1, 5:1, 2.5:1, and 1:1) while there was a crete multiple stimulatory factors. These factors include FGF, BDNF, IGF, NGF, and TGF (18) , which provide marked decrease in TH-positive neurons at a ratio VM: SCs 1:5 after 7 DIV (34) .
neurotrophic support and enhance tissue repair. Also mature reactive astrocytes produce vascular endothelial All grafts had an effect on the host striatum inflammatory response. MHC II-positive (activated) cells were growth factor (VEGF), which helps in the process of angiogenesis (24) . found in the transplant site in all the groups, although it was more extensive in the xenograft conditions. This
The mechanism by which the SCs induce immune privilege is still unknown. It may be that by optimizing response can be explained as a posttraumatic brain injury response. After mild CNS injury, activated microg-the age of SCs and ratio of SCs to transplanted cells for enhancing TH expression in dopaminergic neurons (41) lia/macrophage clear debris resulting from dead cells and enhance CNS recovery (33) . However, activated mi-we decreased the ability of the cells to provide immune protection to cografted cells. SCs can protect xeno-croglia play a role in immune regulation through antigen presentation and lymphocytic activation (11) . A previ-grafted islets from destruction in animal models of diabetes (43) . We showed that SCs also express TGF-β. ous study showed that only in xenograft conditions did the micoglia act as antigen-presenting cells in the brain This is consistent with studies of SC-islet cotransplant showing that TGF-β was highly expressed by SCs while parenchyma, which was sufficient enough to induce graft rejection and destruction (35) . Therefore, the ex-Fas L expression was low (23). Further, the immune protective effect of SCs was dependent on TGF-β secre-pression of major histocompatibility complex antigens may lead to graft rejection, especially in cases of xeno-tion (39) .
Our results suggested that mouse tissue and the grafting (15). However, further studies are needed to examine MHC expression of SCs in vivo. mouse immune response are different from the response in the rat. Larsson and colleagues showed that all grafts The presence of the MHC I antigen on the SCs may have contributed to their destruction over time within in a rat-to-guinea pig xenograft survived for 2 weeks, while all grafts in mouse-to-guinea pig xenografts were the xenografts. It was shown by Duan et al. that when dopamine neurons were obtained from either MHC I-or rejected 2 weeks posttransplant (26) . Another study using porcine neural xenografts in rats and mice showed II-deficient mice, there was better survival at 6 weeks posttransplant compared to dopamine neurons obtained that, at 4-6 weeks posttransplant in mice, all grafts were already rejected except for one graft that was showing from wild-type mice (14). Brandis and colleagues showed that allografts in rat striatum can survive up to signs of rejection. However, in rats at 6-12 weeks posttransplantation, there were grafts with no signs of rejection 12 weeks without immunosuppression and that the MHC class I expression is not sufficient to produce graft rejec-based on the graft size, number of surviving TH-positive cells, and immunological reaction (27) . A different study tion (5) . In the present study, the rVM expressed little MHC I or MHC II, which may explain why the single showed that rat (allograft) or pig (xenograft) SCs can survive up to 2 months in the rat striatum without the xenograft was initially tolerated by the host mouse, even though there was extensive astrocytic infiltration of the use of systemic immune suppression with cyclosporine (37). In our current study, there was poor survival of graft.
Another brain response to injury is the activation of rSCs and rVM + rSCs groups at 2 months posttransplant. The use of the mouse model might have contrib-astrocytes. There was little astrocytic response to the mVM allograft, but there was extensive astrocytic infil-uted to the poor survival of the grafted cells because xenografts of SCs survived in rats. It may be necessary tration of the rVM xenografts. Cografting with rSC prevented this astrocytic infiltration of the graft; this re-to boost expression of secreted factors in order to further enhance the immunosuppressive factors present in the sponse is reminiscent of the astrogliosis that is observed following brain injury (7) . The significance of this phe-SCs (16). The process of xenotransplantation is a complicated nomenon is unclear and controversial. This might explain the poor survival of SC-only grafts, as these grafts issue and the process of graft rejection is still being investigated. Xenograft rejection (concordant or discor-showed extensive gliosis and scar tissue surrounding the graft. In contrast, the mVM grafts, which had astrocytic dant) is based on humoral antibody response that is either antibody mediated or complement mediated (2, 9) , infiltration, survived much better. Extensive gliosis around the graft has been correlated to chondroitin-6-whereas allograft rejection is a cellular response (17). The MHC molecule is responsible for graft rejection in sulphate proteoglycan and cytotactin/tenascin secretion 
